Sagimet Biosciences Statistics
Share Statistics
Sagimet Biosciences has 30.67M
shares outstanding. The number of shares has increased by -3.88%
in one year.
| Shares Outstanding | 30.67M |
| Shares Change (YoY) | -3.88% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 55.55% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 8,063 |
| FTD / Avg. Volume | 1.38% |
Short Selling Information
The latest short interest is 3.83M, so 11.88% of the outstanding
shares have been sold short.
| Short Interest | 3.83M |
| Short % of Shares Out | 11.88% |
| Short % of Float | 14.19% |
| Short Ratio (days to cover) | 4.93 |
Valuation Ratios
The PE ratio is -3.1 and the forward
PE ratio is -0.78.
Sagimet Biosciences's PEG ratio is
0.07.
| PE Ratio | -3.1 |
| Forward PE | -0.78 |
| PS Ratio | 0 |
| Forward PS | 0.6 |
| PB Ratio | 0.91 |
| P/FCF Ratio | -3.32 |
| PEG Ratio | 0.07 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Sagimet Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 34.3,
with a Debt / Equity ratio of 0.
| Current Ratio | 34.3 |
| Quick Ratio | 34.3 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-3,254,785.71 |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -11.46% in the
last 52 weeks. The beta is 2.36, so Sagimet Biosciences's
price volatility has been higher than the market average.
| Beta | 2.36 |
| 52-Week Price Change | -11.46% |
| 50-Day Moving Average | 3.23 |
| 200-Day Moving Average | 3.99 |
| Relative Strength Index (RSI) | 69.67 |
| Average Volume (20 Days) | 584,168 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -54.45M |
| Net Income | -45.57M |
| EBITDA | -54.45M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.45 |
Full Income StatementBalance Sheet
The company has 75.84M in cash and 78K in
debt, giving a net cash position of 75.76M.
| Cash & Cash Equivalents | 75.84M |
| Total Debt | 78K |
| Net Cash | 75.76M |
| Retained Earnings | -295.31M |
| Total Assets | 160.26M |
| Working Capital | 148.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -42.44M
and capital expenditures 0, giving a free cash flow of -42.44M.
| Operating Cash Flow | -42.44M |
| Capital Expenditures | n/a |
| Free Cash Flow | -42.44M |
| FCF Per Share | -1.35 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
